Showing results (331-340 of 609) with videos related to
Sort By:
Pageof 61
Stroke|August 14, 2019
Younger Age and Depressive Symptoms Predict High Risk of Generalized Anxiety After Stroke and Transient Ischemic AttackArunima Kapoor, Kevin Si, Amy Y X Yu, et al.The Journal of Clinical Psychiatry|January 7, 2011
Major depressive disorder predicts completion, adherence, and outcomes in cardiac rehabilitation: a prospective cohort study of 195 patients with coronary artery diseaseWalter Swardfager, Nathan Herrmann, Susan Marzolini, et al.Archives of General Psychiatry|November 9, 2005
Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probeLescia K Tremblay, Claudio A Naranjo, Simon J Graham, et al.Cardiovascular Psychiatry and Neurology|December 13, 2017
Baseline Oxidative Stress Is Associated with Memory Changes in Omega-3 Fatty Acid Treated Coronary Artery Disease PatientsGraham Mazereeuw, Nathan Herrmann, Ana C Andreazza, et al.The Journal of Clinical Psychiatry|May 6, 2010
A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injuryMark J Rapoport, Robert A Mitchell, Scott McCullagh, et al.Neuroscience and Biobehavioral Reviews|April 10, 2013
Potential roles of zinc in the pathophysiology and treatment of major depressive disorderWalter Swardfager, Nathan Herrmann, Roger S McIntyre, et al.Brain, Behavior, and Immunity|October 16, 2016
Oxidative stress predicts depressive symptom changes with omega-3 fatty acid treatment in coronary artery disease patientsGraham Mazereeuw, Nathan Herrmann, Ana C Andreazza, et al.Journal of Clinical Psychopharmacology|August 17, 2016
Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled TrialGraham Mazereeuw, Nathan Herrmann, Paul I Oh, et al.American Journal of Alzheimer'S Disease and Other Dementias|July 28, 2006
Perceptions of natural health products among patients attending a memory clinicPapita Sharma, Nathan Herrmann, Paula A Rochon, et al.Journal of Clinical Psychopharmacology|May 16, 2008
Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challengeNathan Herrmann, Lana S Rothenburg, Sandra E Black, et al.Pageof 61